Accessible complex medicines for patients
Amphastar Pharmaceuticals (amphastar.com) earns a Brand Analyzer score of 66 out of 100, placing it in the Developing tier among Healthcare brands, Manufacturing brands. Among 3448 Healthcare brands analyzed, Amphastar Pharmaceuticals ranks in the 25th percentile (category average 72, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 77/100, Digital Presence 82/100, Visual Identity 70/100, Messaging Clarity 95/100, Trust Foundation 77/100, AI Discoverability 28/100, Brand Authority 35/100.
Amphastar Pharmaceuticals is a publicly traded American pharmaceutical company founded in 1996. It develops, manufactures, and markets complex injectable, intranasal, inhalation, and biologic medications, including biosimilars and generics. The company focuses on hard-to-manufacture drugs, aiming to provide more affordable alternatives to costly branded treatments. Its customers include healthcare providers, hospitals, pharmacies, and patients who rely on these critical care medications.
| Brand Name | Amphastar Pharmaceuticals |
|---|---|
| Domain | amphastar.com |
| Industry | Healthcare, Manufacturing |
| Founded | 1996 |
| Main Competitors | Teva Pharmaceutical Industries, Viatris (Mylan), Fresenius Kabi, Hikma Pharmaceuticals, Sandoz, Pfizer (Hospira) (89/100), Sun Pharmaceutical Industries |
Moz Domain Authority 43/100 vs category average 35 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,943,051 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Amphastar Pharmaceuticals has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "To develop, manufacture, and market high-quality injectable, intranasal, inhalation, and complex biologic medications that improve patient access to essential treatments." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: ASP.NET.
Social footprint: verified profiles on Instagram; no detected presence on X (Twitter), LinkedIn, Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Amphastar Pharmaceuticals scores 48/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Amphastar Pharmaceuticals has a limited AI-visibility profile at 48/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (63/100) and its weakest is trust (26/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #1,943,051 (Tranco). The main gaps holding it back: thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Amphastar Pharmaceuticals from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Amphastar Pharmaceuticals?", Claude could identify the brand as of August 2026. Amphastar Pharmaceuticals is a specialty pharmaceutical company that develops, manufactures, and markets generic and proprietary injectable, inhalation, and intranasal products, including drugs used in emergency and critical care settings. Best known for Manufacturing generic injectable drugs like epinephrine and naloxone, as well as consumer products like Primatene Mist.
When asked "Best brands similar to Amphastar Pharmaceuticals?", Claude would recommend Amphastar Pharmaceuticals as of August 2026. It's a legitimate mid-size generics and specialty pharma player worth mentioning for injectable and emergency medication manufacturing.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Amphastar Pharmaceuticals's main competitors include Teva Pharmaceutical Industries, Viatris (Mylan), Fresenius Kabi, Hikma Pharmaceuticals, Sandoz. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Amphastar Pharmaceuticals and Pfizer (Hospira) are competitors in Healthcare. Brand Analyzer scores Amphastar Pharmaceuticals at 66/100 and Pfizer (Hospira) at 89/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Amphastar Pharmaceuticals include Teva Pharmaceutical Industries, Viatris (Mylan), Fresenius Kabi, Hikma Pharmaceuticals, Sandoz. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Amphastar offers injectable, intranasal, inhalation, and complex biologic medications, including biosimilars and generic versions of branded drugs used in critical and essential care settings.
Amphastar Pharmaceuticals is a publicly traded American pharmaceutical company, founded in 1996, that specializes in developing, manufacturing, and marketing complex injectable, intranasal, inhalation, and biologic medications.
Amphastar Pharmaceuticals has limited AI-search visibility, scoring 48/100 on Brand Analyzer's AI visibility composite (visibility 63, trust 26, recommendation 49). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Amphastar Pharmaceuticals was founded in 1996. Amphastar Pharmaceuticals operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Amphastar develops, manufactures, and markets high-quality injectable, intranasal, inhalation, and complex biologic medications, including biosimilars and generic drugs, with a focus on improving patient access to essential treatments.
Amphastar Pharmaceuticals scores 49/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Amphastar Pharmaceuticals can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Amphastar's products are used by healthcare providers, hospitals, pharmacies, and patients who require injectable, intranasal, inhalation, or complex biologic medications.
Amphastar is known for specializing in complex, hard-to-manufacture medications such as injectables and biosimilars, providing more affordable alternatives to expensive branded drugs in critical care medicine.
Ranked closest to Amphastar Pharmaceuticals: Altermed RCM (66/100), Alphaeon (66/100), Azara Healthcare (66/100), bioandbrainhealthinfo (66/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Elsevier (96/100).